The Stimulatory Effects of Intracellular α-Synuclein on Synaptic Transmission Are Attenuated by 2-Octahydroisoquinolin-2(1H)-ylethanamine.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Dec 2021
Historique:
received: 19 10 2021
revised: 23 11 2021
accepted: 25 11 2021
entrez: 24 12 2021
pubmed: 25 12 2021
medline: 2 2 2022
Statut: epublish

Résumé

α-Synuclein (αSyn) species can be detected in synaptic boutons, where they play a crucial role in the pathogenesis of Parkinson's Disease (PD). However, the effects of intracellular αSyn species on synaptic transmission have not been thoroughly studied. Here, using patch-clamp recordings in hippocampal neurons, we report that αSyn oligomers (αSynO), intracellularly delivered through the patch electrode, produced a fast and potent effect on synaptic transmission, causing a substantial increase in the frequency, amplitude and transferred charge of spontaneous synaptic currents. We also found an increase in the frequency of miniature synaptic currents, suggesting an effect located at the presynaptic site of the synapsis. Furthermore, our in silico approximation using docking analysis and molecular dynamics simulations showed an interaction between a previously described small anti-amyloid beta (Aβ) molecule, termed M30 (2-octahydroisoquinolin-2(1H)-ylethanamine), with a central hydrophobic region of αSyn. In line with this finding, our empirical data aimed to obtain oligomerization states with thioflavin T (ThT) and Western blot (WB) indicated that M30 interfered with αSyn aggregation and decreased the formation of higher-molecular-weight species. Furthermore, the effect of αSynO on synaptic physiology was also antagonized by M30, resulting in a decrease in the frequency, amplitude, and charge transferred of synaptic currents. Overall, the present results show an excitatory effect of intracellular αSyn low molecular-weight species, not previously described, that are able to affect synaptic transmission, and the potential of a small neuroactive molecule to interfere with the aggregation process and the synaptic effect of αSyn, suggesting that M30 could be a potential therapeutic strategy for synucleinopathies.

Identifiants

pubmed: 34948050
pii: ijms222413253
doi: 10.3390/ijms222413253
pmc: PMC8705949
pii:
doi:

Substances chimiques

Benzothiazoles 0
Isoquinolines 0
SNCA protein, human 0
alpha-Synuclein 0
thioflavin T 2390-54-7

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT)
ID : 1140473
Organisme : Fondo Nacional de Desarrollo Científico y Tecnológico (FONDECYT)
ID : 1180752

Références

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13010-5
pubmed: 19651612
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Cell Tissue Res. 2018 Jul;373(1):137-148
pubmed: 29119326
Cell Death Differ. 1998 Oct;5(10):832-7
pubmed: 10203692
Acta Neuropathol. 2021 Jul;142(1):87-115
pubmed: 33978813
Neuron. 1995 Feb;14(2):467-75
pubmed: 7857654
J Pharmacol Exp Ther. 1994 Jul;270(1):61-9
pubmed: 8035343
J Neurosci. 2010 Jun 16;30(24):8083-95
pubmed: 20554859
J Neurosci. 2019 Jun 26;39(26):5080-5094
pubmed: 31036761
Cell Res. 2018 Sep;28(9):897-903
pubmed: 30065316
J Biol Chem. 2001 Jul 20;276(29):27441-8
pubmed: 11316809
Nat Rev Neurosci. 2013 Jan;14(1):38-48
pubmed: 23254192
Science. 1997 Jun 27;276(5321):2045-7
pubmed: 9197268
Aging Cell. 2021 Sep;20(9):e13455
pubmed: 34409748
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9
pubmed: 21325059
PLoS One. 2017 Sep 25;12(9):e0184040
pubmed: 28945746
Elife. 2018 Jul 03;7:
pubmed: 29969391
Int J Mol Sci. 2017 Mar 02;18(3):
pubmed: 28257086
Neurobiol Dis. 2014 May;65:82-92
pubmed: 24412310
Neuron. 1997 Jun;18(6):995-1008
pubmed: 9208866
Nat Commun. 2021 Feb 10;12(1):927
pubmed: 33568632
Parkinsons Dis. 2015;2015:546462
pubmed: 26635992
J Cell Sci. 2004 Mar 1;117(Pt 7):1017-24
pubmed: 14996933
Sci Rep. 2019 Nov 4;9(1):15977
pubmed: 31685859
J Neurochem. 2009 Jul;110(1):400-11
pubmed: 19457104
Proc Natl Acad Sci U S A. 2009 Mar 3;106(9):3348-53
pubmed: 19204293
J Neurosci. 2010 Mar 3;30(9):3409-18
pubmed: 20203200
J Physiol. 2015 Jan 1;593(1):145-59
pubmed: 25556793
J Neurosci. 2007 Feb 7;27(6):1405-10
pubmed: 17287515
Perspect Medicin Chem. 2014 Jun 16;6:11-24
pubmed: 24963272
J Neurochem. 2001 Jul;78(2):384-95
pubmed: 11461974
R Soc Open Sci. 2017 Jan 4;4(1):160696
pubmed: 28280572
J Neurosci. 2006 Nov 15;26(46):11915-22
pubmed: 17108165
Phys Chem Chem Phys. 2018 Feb 7;20(6):4502-4512
pubmed: 29372732
J Parkinsons Dis. 2017;7(s1):S51-S69
pubmed: 28282814
Neural Regen Res. 2018 Apr;13(4):616-623
pubmed: 29722304
Int J Biochem Cell Biol. 2008;40(9):1835-49
pubmed: 18291704
Neurobiol Dis. 2020 Jul;141:104938
pubmed: 32434047
J Chem Theory Comput. 2013 Jul 9;9(7):3084-95
pubmed: 26583988
Mol Biosyst. 2013 Aug;9(8):2118-24
pubmed: 23708585
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Eur J Neurosci. 2010 Jul;32(1):10-7
pubmed: 20550572
J Neurochem. 2015 Mar;132(6):731-41
pubmed: 25669123
J Physiol. 2016 May 15;594(10):2751-72
pubmed: 26915902
Mol Biol Cell. 2014 Dec 1;25(24):3926-41
pubmed: 25273557
J Neurosci. 2000 May 1;20(9):3214-20
pubmed: 10777786
Acta Neuropathol. 2019 Oct;138(4):535-550
pubmed: 31254094
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):20051-6
pubmed: 19892735
Proc Natl Acad Sci U S A. 2000 Jan 18;97(2):571-6
pubmed: 10639120
J Neurosci. 2010 May 19;30(20):6838-51
pubmed: 20484626
Trends Mol Med. 2020 Apr;26(4):408-421
pubmed: 32277934
Front Aging Neurosci. 2018 Aug 03;10:226
pubmed: 30123122
Proc Natl Acad Sci U S A. 2018 Oct 9;115(41):10481-10486
pubmed: 30249646
Biopolymers. 1983 Dec;22(12):2577-637
pubmed: 6667333
Neurosci Lett. 1999 Apr 9;265(1):67-9
pubmed: 10327208
J Clin Invest. 2011 Feb;121(2):715-25
pubmed: 21245577
Ann Neurol. 2012 Oct;72(4):517-24
pubmed: 23109146
Neurobiol Aging. 2014 Mar;35(3):472-81
pubmed: 24112789
Acta Neuropathol Commun. 2019 Jul 12;7(1):113
pubmed: 31300049
J Neurosci. 2008 Nov 19;28(47):12305-17
pubmed: 19020024
Nature. 2018 May;557(7706):558-563
pubmed: 29743672
Nucleic Acids Res. 2015 Jan;43(Database issue):D364-8
pubmed: 25352545
J Biol Chem. 2014 Jul 18;289(29):19839-40
pubmed: 24860092
Curr Pharm Des. 2016;22(10):1295-304
pubmed: 26972288
J Neurochem. 2016 Oct;139 Suppl 1:216-231
pubmed: 27546335
J Neurosci. 1988 Aug;8(8):2804-15
pubmed: 3411354
FEBS Lett. 1998 Nov 27;440(1-2):71-5
pubmed: 9862428
Brain Res. 2004 Apr 9;1004(1-2):61-72
pubmed: 15033420
J Biol Chem. 2010 Jan 22;285(4):2506-14
pubmed: 19915004
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3105-3116
pubmed: 28844949
J Biol Chem. 2001 Jan 26;276(4):2380-6
pubmed: 11060312
J Biol Chem. 2010 Apr 30;285(18):13621-9
pubmed: 20200163
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804
Proteins. 2020 Oct;88(10):1285-1302
pubmed: 32419254
Cold Spring Harb Perspect Med. 2012 Feb;2(2):a009399
pubmed: 22355802
Acta Neuropathol Commun. 2021 Feb 25;9(1):31
pubmed: 33632316

Auteurs

Alejandra E Ramirez (AE)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.

Eduardo J Fernández-Pérez (EJ)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.

Nicol Olivos (N)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.

Carlos F Burgos (CF)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.

Subramanian Boopathi (S)

Instituto de Ciencias Físicas, Universidad Nacional Autónoma de México, Cuernavaca 62210, Mexico.
Center for Bioinformatics, Simulations and Modeling, The Center for Bioinformatics and Molecular Simulations (CBSM), University of Talca, Talca 3530000, Chile.

Lorena Armijo-Weingart (L)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.

Carla R Pacheco (CR)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.

Wendy González (W)

Center for Bioinformatics, Simulations and Modeling, The Center for Bioinformatics and Molecular Simulations (CBSM), University of Talca, Talca 3530000, Chile.
Millennium Nucleus of Ion Channels-Associated Diseases, The Center for Bioinformatics and Molecular Simulations (CBSM), University of Talca, Talca 3530000, Chile.

Luis G Aguayo (LG)

Laboratory of Neurophysiology, Department of Physiology, Faculty of Biological Sciences, Universidad de Concepción, 160-C, Concepción 4030000, Chile.
Programa de Neurociencia, Psiquiatría y Salud Mental, Anatomy Building,Faculty of Medicine, Universidad de Concepción, Concepción 4030000, Chile.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH